ANIX · Anixa Biosciences Inc · Financials
Market Cap
$101.22M
Shares
34.02M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$210K
0%
FY2024
Net Income
-$10.93M
+13%
FY2025
Gross Margin
99.59%
+3pp
FY2012
Operating Margin
-6586.19%
-1342.9pp
FY2024
Diluted EPS
-$0.34
+12.8%
FY2025
Operating Cash Flow
-$7.17M
+2.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | $210K | $210K | — | $512K | — | $250K | $1.11M | $362.5K | $300K | $9.26M | $3.67M | $388.85K | $940.01K | $1M | $730.68K | |
| $28.99K | — | — | — | — | — | — | — | — | — | — | — | — | — | $3873 | $34.08K | $82.31K | |
| -$26.51K | — | — | — | — | — | — | — | — | — | — | — | — | — | $936.14K | $969.11K | $648.37K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | 99.59% | 96.6% | 88.74% | |
| $4.56M | $5.07M | $6.4M | $4.77M | $6.7M | $6.19M | $4.38M | $5.47M | $6.81M | $1.6M | $1.56M | $711.39K | — | — | $2.21M | $3.12M | $3.01M | |
| $6.12M | $6.63M | $7.44M | $6.29M | $7.17M | $7.07M | $5.6M | $5.66M | — | — | — | — | — | — | — | — | — | |
| $4.9M | — | — | — | — | — | — | $5.66M | $6.91M | $4.41M | $2.71M | $5.51M | $6.41M | $7.99M | $2.86M | $2.87M | $2.89M | |
| — | — | — | — | — | — | — | $418.75K | $325.3K | $325.3K | $325.3K | $325.29K | $314.45K | — | — | — | — | |
| $29.17K | — | — | — | — | — | — | — | $18.44K | $43.22K | $33.33K | $12.52K | — | — | $7234 | $7977 | — | |
| $10.68M | $11.7M | $13.83M | $11.22M | $13.88M | $13.65M | $9.98M | $12.14M | $15.4M | $6.44M | $4.81M | $10.2M | $8.71M | $8.31M | $5.07M | $6.03M | $5.98M | |
| -$10.68M | -$11.7M | -$13.83M | -$11.01M | -$13.88M | -$13.14M | -$9.98M | -$11.89M | -$14.29M | -$6.08M | -$4.51M | -$944.76K | -$5.04M | -$7.92M | -$4.13M | -$5.03M | -$5.25M | |
| — | — | -6586.19% | -5243.33% | — | -2565.62% | — | -4756% | -1284.41% | -1676.02% | -1503% | -10.21% | -137.54% | -2036.17% | -439.84% | -501.23% | -718.27% | |
| -$18.56M | — | — | — | — | — | — | — | -$14.27M | -$6.03M | -$4.48M | -$932.24K | — | — | -$4.13M | -$5.02M | — | |
| — | — | — | — | — | — | — | — | — | $500.46K | $519.95K | $451.91K | $1.26M | $1.11M | $7664 | — | — | |
| $61.38K | — | — | — | — | — | — | $71.35K | $45.97K | $19.44K | $12.53K | $17.62K | $8595 | $125 | $3458 | $2516 | $4878 | |
| — | — | — | — | — | $5000 | — | — | — | — | — | — | — | — | — | — | — | |
| -$9.55M | — | — | — | — | — | — | -$11.82M | -$14.24M | -$5.01M | -$5.02M | -$1.38M | -$9.61M | -$10.08M | -$4.25M | -$6.78M | -$5.18M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $600K | — | |
| -$10.03M | -$10.93M | -$12.55M | -$9.81M | -$13.6M | -$12.95M | -$10.02M | -$11.65M | -$14M | -$5.01M | -$5.02M | -$1.38M | -$9.61M | -$10.08M | -$4.25M | -$7.38M | -$5.18M | |
| — | — | -5978.1% | -4671.9% | — | -2530.08% | — | -4658.82% | -1258.07% | -1381.79% | -1672.14% | -14.9% | -261.94% | -2592.28% | -452.42% | -735.46% | -708.27% | |
| -$89K | -$101K | -$144K | -$119K | -$176K | -$174K | -$74.01K | -$171.6K | -$247.06K | — | — | — | — | — | — | — | — | |
| -$9.46M | — | — | — | — | — | — | -$11.65M | -$14M | -$7.02M | — | — | — | — | — | — | — | |
| -$3.19M | — | — | — | — | — | — | — | — | — | — | — | -$9.61M | -$9.43M | -$4.91M | — | — | |
| USD/shares | -$0.30 | -$0.34 | -$0.39 | -$0.32 | $0.45 | -$0.45 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$0.30 | -$0.34 | -$0.39 | -$0.32 | $0.45 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 32.45K | 31.9K | 30.98K | 30.37K | 28.58M | 22.23M | 19.79M | 17.62M | 12.2M | 8.74M | 8.76M | 8.71M | 196.65M | 181.68M | 166.86M | — |
| shares | — | 32.45K | 31.9K | 30.98K | 30.37K | 28.58M | 22.23M | 19.79M | 17.62M | 12.2M | 8.74M | 8.76M | 8.71M | 196.65M | 181.68M | 166.86M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 6.58×
EV/EBIT
—
Peer median 11.84×
P/E (TTM)
—
Peer median 8.64×
Peer medians compare against the 307 similar-size Biotechnology companies (of 537 listed).
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Other | -$54,000 | -$60,000 |
| Cart Therapeutics | -$4,453,000 | -$5,732,000 |
| Cancer Vaccines | -$7,394,000 | -$8,039,000 |
Key facts
CIK
715446
CUSIP
03528H109
13F (30d)
38 filings
38 filers
Visit website
Investor relations